1/2/22, 5:10 PM
`
`Suzhou PengXu PharmaTech Co., Ltd.Product Catalog_Page1_ChemicalBook
`
` Sign in | Join free
`
`Please enter the CAS nu
`
`Suzhou PengXu PharmaTech Co., Ltd.
`
`Product Catalog
`
`Current Location: HOME >> Product
`
`Product Categories
`
`Product Name
`
`(2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)aMino)-2-
`Methylpentanoic acid
`
`Company Nam
`e:
`Tel:
`Fax:
`Email:
`WebSite:
`Product Total:
`CB Index:
`Nationality:
`
`Suzhou PengXu PharmaTech Co., Lt
`d.
`18362508876 0512-62956066-
`
`3-(1-Biphenyl-4-ylMethyl-3-ethoxycarbonyl-1-butylcarbaMoyl)propionate-
`3'-Methyl-2'-(pentanoyl(2'-(tetrazol-5-ylate)biphenyl-4'-
`ylMethyl)aMino)butyrate
`
`5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyriMidin-4-ylaMine;
`
`sales@pengxupharma.com.cn
`www.pengxupharma.com.cn
`88
`58
`China
`
`AHU-377 (heMicalciuM salt)
`
`Ibrutinib
`
`N-[(1S)-3-Methyl-1-[[(2R)-2-Methyl-2-oxiranyl]carbonyl]butyl]-CarbaMic
`acid, 1,1-diMethylethyl ester
`
`Sacubitril
`
`Treprostinil intermediate 1；(4-Hydroxy-nonyl)-phosphonic acid dimethyl
`ester
`
`Treprostinil intermediate 2
`
`4-(4-cyclopropylnaphthalen-1-yl)-1H-1,2,4-triazole-5(4H)-thione
`
`brivaracetam
`
`Methyl 2-[[4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-
`yl]thio]acetate
`
`MF
`
`C23H29NO4
`
`C48H58N6O8
`
`C17H13N5O
`
`C48H56CaN2O10
`
`C25H24N6O2
`
`C14H25NO4
`
`C24H29NO5
`
`C11H25O4P
`
`C16H33O5P
`
`C15H13N3S
`
`C11H20N2O2
`
`C18H17N3O2S
`
`5-Biphenyl-4-yl-4-tert-butoxycarbonylamino-2-methyl-pent-2-enoic acid C23H27NO4
`
`(2Z,5Z)-5-(3-chloro-4-((R)-2,3-dihydroxypropoxy)benzylidene)-2-
`(propyliMino)-3-(o-tolyl)thiazolidin-4-one
`
`Filgotinib (GLPG0634)
`
`C23H25ClN2O4S
`
`C21H23N5O3S
`
`C10H19NO3
`
`CAS
`
`10123
`
`93662
`
`33078
`
`13697
`
`93656
`
`24706
`
`14970
`
`15936
`
`10169
`
`15335
`
`35733
`
`15335
`
`10123
`
`85410
`
`12061
`
`14390
`
`(S)-1-Boc-3-hydroxypiperidine
`
`(2R,4S)-ethyl 5-([1,1'-biphenyl]-4-yl)-4-aMino-2-Methylpentanoate
`
`C20H26ClNO2
`
`Rolapitant
`
`(2S,4R)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-
`methylpentanoic acid
`
`1012341-48-8 enantioMer
`
`1426129-50-1 enantioMer
`
`Galeterone
`
`C25H26F6N2O2
`
`C23H29NO4
`
`C23H27NO4
`
`C20H25NO3
`
`C26H32N2O
`
`1-[[2-(4-Chlorophenyl)-4,4-dimethylcyclohex-1-enyl]methyl]piperazine
`
`C19H27ClN2
`
`ARN-509
`
`C21H15F4N5O2S
`
`Benzonitrile, 5-[3-[(1S)-2,3-dihydro-1-[(2-hydroxyethyl)aMino]-1H-inden-4-
`yl]-1,2,4-oxadiazol-5-yl]-2-(1-Methylethoxy)- (HCl salt)
`
`C23H25ClN4O3
`
`ABT199 intermediates
`
`Vadadustat
`
`1,6-NAPHTHYRIDINE-3-CARBOXAMIDE, 4-(4-CYANO-2-
`METHOXYPHENYL)-5-ETHOXY-1,4-DIHYDRO-2,8-DIMETHYL-, (4R)-
`
`4-(4-Cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-
`naphthyridine-3-carboxamide
`
`Lemborexant
`
`(R)-3-(4-phenoxyphenyl)-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-
`amine dihydrochloride
`
`C15H11FN2O3
`
`C14H11ClN2O4
`
`C21H22N4O3
`
`C21H22N4O3
`
`C22H20F2N4O2
`
`C22H24Cl2N6O
`
`2-(4-chlorophenyl)-4,4-dimethyl-1-cyclohexene-1-carboxaldehyde
`
`C15H17ClO
`
`Finerenone
`
`Methyl 2-[(1H-pyrrolo[2,3-b]pyridin-5-yl)oxy]-4-[4-[[2-(4-chlorophenyl)-4,4-
`dimethylcyclohex-1-enyl]methyl]piperazin-1-yl]benzoate
`
`Pimodivir (VX-787)
`
`C21H22N4O3
`
`C34H37ClN4O3
`
`C20H19F2N5O2
`
`https://www.chemicalbook.com/ShowSupplierProductsList17080/0_EN.htm
`
`14969
`
`55229
`
`10123
`
`10150
`
`15303
`
`85198
`
`12287
`
`95610
`
`13067
`
`12358
`
`10000
`
`10504
`
`10504
`
`13697
`
`17014
`
`12288
`
`10504
`
`12358
`
`16298
`
`1/3
`
`Rogers
`1/6/2022
`Exhibit 1046
`
`Page 1 of 3
`
`EISAI EXHIBIT 1046
`Eisai v. Crystal Pharm.
`PGR2021-00047
`
`
`
`Suzhou PengXu PharmaTech Co., Ltd.Product Catalog_Page1_ChemicalBook
`
` Sign in | Join free
`
`Please enter the CAS nu
`
`Suzhou PengXu PharmaTech Co., Ltd.
`
`Product Catalog
`
`Current Location: HOME >> Product
`
`Product Categories
`
`Product Name
`
`(2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)aMino)-2-
`Methylpentanoic acid
`
`Company Nam
`e:
`Tel:
`Fax:
`Email:
`WebSite:
`Product Total:
`CB Index:
`Nationality:
`
`Suzhou PengXu PharmaTech Co., Lt
`d.
`18362508876 0512-62956066-
`
`3-(1-Biphenyl-4-ylMethyl-3-ethoxycarbonyl-1-butylcarbaMoyl)propionate-
`3'-Methyl-2'-(pentanoyl(2'-(tetrazol-5-ylate)biphenyl-4'-
`ylMethyl)aMino)butyrate
`
`5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyriMidin-4-ylaMine;
`
`sales@pengxupharma.com.cn
`www.pengxupharma.com.cn
`88
`58
`China
`
`AHU-377 (heMicalciuM salt)
`
`Ibrutinib
`
`N-[(1S)-3-Methyl-1-[[(2R)-2-Methyl-2-oxiranyl]carbonyl]butyl]-CarbaMic
`acid, 1,1-diMethylethyl ester
`
`Sacubitril
`
`Treprostinil intermediate 1；(4-Hydroxy-nonyl)-phosphonic acid dimethyl
`ester
`
`Treprostinil intermediate 2
`
`4-(4-cyclopropylnaphthalen-1-yl)-1H-1,2,4-triazole-5(4H)-thione
`
`brivaracetam
`
`Methyl 2-[[4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-
`yl]thio]acetate
`
`MF
`
`C23H29NO4
`
`C48H58N6O8
`
`C17H13N5O
`
`C48H56CaN2O10
`
`C25H24N6O2
`
`C14H25NO4
`
`C24H29NO5
`
`C11H25O4P
`
`C16H33O5P
`
`C15H13N3S
`
`C11H20N2O2
`
`C18H17N3O2S
`
`5-Biphenyl-4-yl-4-tert-butoxycarbonylamino-2-methyl-pent-2-enoic acid C23H27NO4
`
`(2Z,5Z)-5-(3-chloro-4-((R)-2,3-dihydroxypropoxy)benzylidene)-2-
`(propyliMino)-3-(o-tolyl)thiazolidin-4-one
`
`Filgotinib (GLPG0634)
`
`C23H25ClN2O4S
`
`C21H23N5O3S
`
`C10H19NO3
`
`CAS
`
`10123
`
`93662
`
`33078
`
`13697
`
`93656
`
`24706
`
`14970
`
`15936
`
`10169
`
`15335
`
`35733
`
`15335
`
`10123
`
`85410
`
`12061
`
`14390
`
`(S)-1-Boc-3-hydroxypiperidine
`
`(2R,4S)-ethyl 5-([1,1'-biphenyl]-4-yl)-4-aMino-2-Methylpentanoate
`
`C20H26ClNO2
`
`Rolapitant
`
`(2S,4R)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-
`methylpentanoic acid
`
`1012341-48-8 enantioMer
`
`1426129-50-1 enantioMer
`
`Galeterone
`
`C25H26F6N2O2
`
`C23H29NO4
`
`C23H27NO4
`
`C20H25NO3
`
`C26H32N2O
`
`1-[[2-(4-Chlorophenyl)-4,4-dimethylcyclohex-1-enyl]methyl]piperazine
`
`C19H27ClN2
`
`ARN-509
`
`C21H15F4N5O2S
`
`Benzonitrile, 5-[3-[(1S)-2,3-dihydro-1-[(2-hydroxyethyl)aMino]-1H-inden-4-
`yl]-1,2,4-oxadiazol-5-yl]-2-(1-Methylethoxy)- (HCl salt)
`
`C23H25ClN4O3
`
`ABT199 intermediates
`
`Vadadustat
`
`1,6-NAPHTHYRIDINE-3-CARBOXAMIDE, 4-(4-CYANO-2-
`METHOXYPHENYL)-5-ETHOXY-1,4-DIHYDRO-2,8-DIMETHYL-, (4R)-
`
`4-(4-Cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-
`naphthyridine-3-carboxamide
`
`Lemborexant
`
`(R)-3-(4-phenoxyphenyl)-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-
`amine dihydrochloride
`
`C15H11FN2O3
`
`C14H11ClN2O4
`
`C21H22N4O3
`
`C21H22N4O3
`
`C22H20F2N4O2
`
`C22H24Cl2N6O
`
`2-(4-chlorophenyl)-4,4-dimethyl-1-cyclohexene-1-carboxaldehyde
`
`C15H17ClO
`
`Finerenone
`
`Methyl 2-[(1H-pyrrolo[2,3-b]pyridin-5-yl)oxy]-4-[4-[[2-(4-chlorophenyl)-4,4-
`dimethylcyclohex-1-enyl]methyl]piperazin-1-yl]benzoate
`
`Pimodivir (VX-787)
`
`C21H22N4O3
`
`C34H37ClN4O3
`
`C20H19F2N5O2
`
`https://www.chemicalbook.com/ShowSupplierProductsList17080/0_EN.htm
`
`14969
`
`55229
`
`10123
`
`10150
`
`15303
`
`85198
`
`12287
`
`95610
`
`13067
`
`12358
`
`10000
`
`10504
`
`10504
`
`13697
`
`17014
`
`12288
`
`10504
`
`12358
`
`16298
`
`1/3
`
`Rogers
`1/6/2022
`Exhibit 1046
`
`Page 1 of 3
`
`EISAI EXHIBIT 1046
`Eisai v. Crystal Pharm.
`PGR2021-00047
`
`
`
`1/2/22, 5:10 PM
`
`Suzhou PengXu PharmaTech Co., Ltd.Product Catalog_Page1_ChemicalBook
`tert-butyl 4-((4'-chloro-5,5-diMethyl-3,4,5,6-tetrahydro-[1,1'-biphenyl]-2-
`C24H35ClN2O2
`yl)Methyl)piperazine-1-carboxylate
`
`Upadacitinib
`
`Vilaprisan
`
`4-cyclopropylnaphthalen-1-aMine hydrochloride
`
`Cabotegravir
`
`(2S)-2-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)-1-
`Pyrrolidinecarboxylic acid phenylmethyl ester
`
`4-(Pyridin-2-yl)aminocarbonylphenylboronicacid
`
`Talazoparib
`
`BMN 673
`
`2-Fluoro-6-(trifluoromethyl)benzylamine
`
`C17H19F3N6O
`
`C27H29F5O4S
`
`C13H14ClN
`
`C19H17F2N3O5
`
`C18H18BrN5O2
`
`C12H11BN2O3
`
`C19H14F2N6O
`
`C19H14F2N6O
`
`C8H7F4N
`
`1-(2-Fluoro-6-trifluoromethyl-benzyl)-6-methyl-1H-pyrimidine-2,4-dione
`
`C13H10F4N2O2
`
`1-(2-fluoro-6-(trifluoromethyl)benzyl)-5-iodo-6-methylpyrimidine-
`2,4(1H,3H)-dione
`
`2-Fluoro-3-Methoxyphenylboronic acid
`
`5-(2-Fluoro-3-methoxyphenyl)-1-[[2-fluoro-6-
`(trifluoromethyl)phenyl]methyl]-6-methyl-2,4(1H,3H)-pyrimidinedione
`
`Lumicitabine
`
`Daprodustat
`
`(4-chloro-3-(4-ethoxybenzyl)phenyl)((3aS,5R,6S,6aS)-6-hydroxy-
`
`Rosiptor;AQX-1125
`
`SAGE-217
`
`C13H9F4IN2O2
`
`C7H8BFO3
`
`C20H15F5N2O3
`
`C18H25ClFN3O6
`
`C19H27N3O6
`
`C23H25ClO6
`
`C20H35NO2
`
`C25H35N3O2
`
`(S)-benzyl 2-(1-bromo-8-chloroimidazo[1,5-a]pyrazin-3-yl)pyrrolidine-1-
`carboxylate
`
`C18H16BrClN4O2
`
`N-Pyridin-2-yl-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzamide C18H21BN2O3
`
`(2-Fluoro-6-(trifluoromethyl)phenyl)methanamine hydrochloride
`
`C8H8ClF4N
`
`Gefapixant
`
`Valbenazine tosylate
`
`Selonsertib
`
`C14H19N5O4S
`
`C31H46N2O7S
`
`C24H24FN7O
`
`12287
`
`13107
`
`12621
`
`15335
`
`10513
`
`14204
`
`85056
`
`12074
`
`12074
`
`23908
`
`83034
`
`11505
`
`35230
`
`11505
`
`14453
`
`96053
`
`11037
`
`78248
`
`16320
`
`14204
`
`13833
`
`64308
`
`10157
`
`16392
`
`14484
`
`Baloxavir marboxil
`
`5-bromo-1-[2-fluoro-6-(trifluoromethyl)benzyl]-6-methylpyrimidine-
`2,4(1H,3H)-dione
`
`BMS-986165
`
`Voxelotor ;GBT 440
`
`Relugolix
`
`C27H23F2N3O7S
`
`C13H9BrF4N2O2
`
`C20H22N8O3
`
`C19H19N3O3
`
`C29H27F2N7O5S
`
`Ethyl 2-amino-4-methyl-5-(4-nitro-phenyl)-thiophene-3-carboxylate
`
`C14H14N2O4S
`
`Aprocitentan;ACT-132577
`
`Risdiplam
`
`MGL-3196
`
`5-Bromo-4,7-diazaindole
`
`C16H14Br2N6O4S
`
`C22H23N7O
`
`C17H12Cl2N6O4
`
`C6H4BrN3
`
`3-nitro-4-(((tetrahydro-2H-pyran-4-yl)methyl)amino)benzenesulfonamide C12H17N3O5S
`
`1-((4'-chloro-5,5-dimethyl-3,4,5,6-tetrahydro-[1,1'-biphenyl]-2-
`yl)methyl)piperazine dihydrochloride
`
`Upadacitinib intermediate2
`
`Abrocitinib
`
`Acalabrutinib
`
`Relugolix intermediate1
`
`Relugolix intermediate4
`
`5-Hydroxy-7-azaindole
`
`(3-Chloropyrazin-2-yl)MethanaMine hydrochloride
`
`N-Tosyl-5-bromo-4,7-diazaindole
`
`ABT-199
`
`Valbenazine
`
`Relugolix intermediate3
`
`Elagolix sodium
`
`C19H29Cl3N2
`
`C18H20N4O4S
`
`C14H21N5O2S
`
`C26H23N7O2
`
`C17H18N2O6S
`
`C26H27F2N3O6S
`
`C7H6N2O
`
`C5H7Cl2N3
`
`C13H10BrN3O2S
`
`C45H50ClN7O7S
`
`C24H38N2O4
`
`C24H21BrF2N2O6S
`
`C32H29F5N3NaO5
`
`https://www.chemicalbook.com/ShowSupplierProductsList17080/0_EN.htm
`
`19856
`
`83034
`
`16093
`
`14463
`
`73778
`
`17407
`
`11035
`
`18253
`
`92050
`
`87578
`
`12287
`
`16280
`
`12011
`
`16229
`
`14204
`
`30883
`
`15895
`
`98549
`
`93941
`
`12011
`
`12570
`
`10255
`
`30883
`
`83272
`
`2/3
`
`Page 2 of 3
`
`
`
`1/2/22, 5:10 PM
`
`Suzhou PengXu PharmaTech Co., Ltd.Product Catalog_Page1_ChemicalBook
`Relugolix intermediate2
`C24H22F2N2O6S
`
`Upadacitinib intermediate5
`
`(3R,4S)-1-((benzyloxy)carbonyl)-4-ethylpyrrolidine-3-carboxylic acid
`Dicyclohexylamine Salt
`
`Relugolix intermediate5
`Product Total： Product Page：
`
`C16H20BrNO3
`
`C27H42N2O4
`
`C24H23F2N3O6S
`
`1
`
`30883
`
`14282
`
`20953
`
`15895
`
`HomePage | About Us | Member Companies | Advertising | Contact us | Previous WebSite | MSDS | CAS Index | CAS DataBase | Product Catalog | Links| Pricacy| Terms| Product Manufacturer
`
`Copyright © 2016 ChemicalBook All rights reserved.
`
`https://www.chemicalbook.com/ShowSupplierProductsList17080/0_EN.htm
`
`3/3
`
`Page 3 of 3
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
